Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?

Canoui, E

Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams? [electronic resource] - Medecine et maladies infectieuses May 2014 - 235-7 p. digital

Publication Type: Letter

1769-6690

10.1016/j.medmal.2014.03.006 doi


Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents--classification
Bacterial Proteins--metabolism
Cross Infection--drug therapy
Drug Resistance, Multiple, Bacterial
Enterobacteriaceae--drug effects
Enterobacteriaceae Infections--drug therapy
Female
France--epidemiology
Humans
Imipenem--pharmacology
Intensive Care Units
Male
Microbial Sensitivity Tests
Middle Aged
Retrospective Studies
Substrate Specificity
beta-Lactam Resistance--genetics
beta-Lactamases--metabolism
beta-Lactams--pharmacology